Dr. Ances’ research focuses on developing novel neuroimaging biomarkers for neurodegenerative diseases- especially Alzheimer’s disease (AD). He concentrates on functional and structural magnetic resonance imaging and positron emission tomography methods to detect early changes in the brain due to AD, and has pioneered the use of advanced neuroimaging techniques (including ASL and BOLD resting state functional connectivity) to study neurodegenerative diseases.
Dr. Beau Ances, MD, PhD, MSc
First published on: June 17, 2021
Last modified on: April 26, 2024